Connor, Clark & Lunn Investment Management Ltd.
Position in NKTR — Nektar Therapeutics
CIK 1596800
VANCOUVER, A1
Position in NKTR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,575,779
-$4,528,923 QoQ
Shares Held
36,897
-62.6% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 239 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. NKTR ranks #43 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in NKTR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,575,779 | 36,897 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,104,702 | 98,745 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,277,298 | 101,166 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,766,307 | 48,617 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $551,296 | 21,335 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $250,446 | 368,304 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $679,713 | 730,875 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $846,093 | 650,841 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $764,140 | 616,242 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $533,865 | 574,049 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $278,163 | 496,720 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $295,185 | 491,975 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $368,104 | 634,663 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $313,758 | 448,227 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $364,599 | 161,327 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $34,268 | 10,709 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $143,780 | 37,837 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $908,091 | 168,477 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $717,408 | 53,102 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $270,029 | 15,736 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||